SIMPLEX TRADING, LLC - ANAVEX LIFE SCIENCES CORP ownership

ANAVEX LIFE SCIENCES CORP's ticker is and the CUSIP is 032797950. A total of 4 filers reported holding ANAVEX LIFE SCIENCES CORP in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SIMPLEX TRADING, LLC ownership history of ANAVEX LIFE SCIENCES CORP
ValueSharesWeighting
Q3 2023$297
-17.0%
45,400
+2.9%
0.00%
Q2 2023$358
+17.8%
44,100
+24.2%
0.00%
Q1 2023$304
-74.4%
35,500
-72.3%
0.00%
-100.0%
Q4 2022$1,188
-99.9%
128,300
-15.3%
0.00%
-50.0%
Q3 2022$1,563,000
+15.4%
151,500
+12.0%
0.00%
+100.0%
Q2 2022$1,354,000
+56.2%
135,300
+91.9%
0.00%0.0%
Q1 2022$867,000
-26.0%
70,500
+4.3%
0.00%0.0%
Q4 2021$1,172,000
-55.6%
67,600
-37.1%
0.00%
-50.0%
Q3 2021$2,638,000
+11.6%
107,400
+3.9%
0.00%0.0%
Q2 2021$2,363,000103,400
+22041.3%
0.00%
Q1 2021$0
-100.0%
467
-20.8%
0.00%
Q4 2020$318,000
+16.1%
590
-2.3%
0.00%
Q3 2020$274,000
+103.0%
604
+118.8%
0.00%
Q2 2020$135,000
+1250.0%
276
+762.5%
0.00%
Q1 2020$10,000
-97.0%
32
-97.5%
0.00%
-100.0%
Q4 2019$335,000
-26.5%
1,295
-10.3%
0.00%0.0%
Q3 2019$456,000
+375.0%
1,444
+403.1%
0.00%
Q2 2019$96,000
+29.7%
287
+18.1%
0.00%
Q1 2019$74,000
+516.7%
243
+203.8%
0.00%
Q4 2018$12,000
-55.6%
80
-21.6%
0.00%
Q3 2018$27,000
-27.0%
102
-28.7%
0.00%
Q2 2018$37,000
+640.0%
143
+60.7%
0.00%
Q1 2018$5,000
-85.3%
89
-65.5%
0.00%
-100.0%
Q4 2017$34,000
+3.0%
258
-0.4%
0.00%0.0%
Q3 2017$33,000
+175.0%
259
+27.6%
0.00%0.0%
Q2 2017$12,000
+9.1%
203
-19.8%
0.00%
Q1 2017$11,000
-90.0%
253
-50.2%
0.00%
-100.0%
Q4 2016$110,000
-26.7%
508
+13.6%
0.01%
-30.0%
Q3 2016$150,000
+1263.6%
447
-2.6%
0.01%
+900.0%
Q2 2016$11,000
-60.7%
459
+68.1%
0.00%
-50.0%
Q1 2016$28,000
-15.2%
273
+43.7%
0.00%
-33.3%
Q4 2015$33,0001900.00%
Other shareholders
ANAVEX LIFE SCIENCES CORP shareholders Q1 2023
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 84,400$456,0000.00%
SIMPLEX TRADING, LLC 590$318,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ANAVEX LIFE SCIENCES CORP shareholders